Return to content in this issue


Cluster sub-analysis of patients with severe asthma who responded to omalizumab

Dávila I1,2, Campo P3, Cimbollek S4, Almonacid Sánchez C5, Quirce S6,7, Moreira A8, Ramirez A8, Soto Campos G9

1Allergy Service, University Hospital of Salamanca and Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain
2Biomedical and Diagnosis Science Department, Salamanca University School of Medicine, Salamanca, Spain
3Allergy Unit, IBIMA-Regional University Hospital of Málaga, ARADyAL, Málaga, Spain
4Department of Allergy, Hospital Universitario Virgen del Rocío, Sevilla, Spain
5Department of Respiratory Medicine, Ramón y Cajal Hospital, IRYCIS, Alcala de Henares University, Madrid, Spain
6Department of Allergy, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
7CIBER de Enfermedades Respiratorias, CIBERES, Madrid, Spain
8Novartis Farmacéutica, Barcelona, Spain
9Pneumology and Allergy Unit, Hospital Universitario de Jerez, Cádiz, Spain

J Investig Allergol Clin Immunol 2022; Vol. 32(3)
doi: 10.18176/jiaci.0731

Key words: IgE, Asthma, Allergens and Epitopes, Eosinophils